アドバイザリーボード
アドバイザリーボードは毎年、重要な動向やタイムリーなテーマについて豊富な知識と経験を提供し、またネットワークを活用して、腫瘍学のイノベーションのリーダーや推進者を登用し、革新的な講演や示唆に富むリーダーシップ、多様な参加者・イノベーターによって、会議が比類ない成功を収めます。
Mara Aspinall
Partner
Illumina Ventures
Christiana Bardon, MD
Co-Managing Partner
MPM BioImpact
Andrea Bild, PhD
Program Manager
Advanced Research Projects Agency for Health (ARPA-H)
Derek DiRocco
Partner
RA Capital Management
Keith J. Figlioli
Managing Partner
LRVHealth
Ben Freeberg
Founder and Managing Partner
Oncology Ventures
Luba Greenwood
Managing Partner, Binney Street Capital
Dana-Farber Cancer Institute
Gregory Grunberg, MD
Head, Life Sciences (North America)
Temasek
Sofia Guerra
Vice President
Bessemer Venture Partners
David Hirsch, MD, PhD
CEO
Alpha-9 Oncology
Karen Hong, PhD
Co-Founder and Co-Owner
Cold Spring Bio
Rachel Humphrey, MD
President and Founding CEO
Normunity
Roger Kitterman
Senior Vice President, Ventures and Business Development & Licensing and Managing Partner
Mass General Brigham Ventures
Selin Kurnaz, PhD
Co-Founder and CEO
Massive Bio
Manoja Lecamwasam, PhD
System Vice President, Intellectual Property and Life Sciences Innovation
CommonSpirit Health
Matt McAviney, MD
Partner
NEA
Marie-Claire Peakman, PhD
Partner, Pfizer Ventures; Executive Director, Worldwide Business Development
Pfizer
Chevon Rariy, MD
Chief Health Officer and
Senior Vice President
Digital Health,
Oncology Care Partners
Maya R. Said, ScD
Founder and CEO
Outcomes4Me
Ajit Singh, PhD
Partner
Artiman Ventures
Dave Stevenson
COO & Managing Director
Merck Global Health Innovation Fund
Shaquille Vayda
Principal
Lux Capital
Carrie Williams
Vice President and Partner
McKesson Ventures
Darshana Zaveri
Founder and Managing Partner
Catalyst Health Ventures